Skip to main content

HilleVax

NYSE tumbleweed
News

Biotech IPO Freeze Continues As Second Quarter Is Slowest In More Than A Decade

Summer weather is heating up but the market for IPOs remains cold.

By Frank Vinluan - MedCityNews